Sign up to access historical data
Similar companies
| Company | Transaction Value | |
|---|---|---|
 |
OcugenOCGN |
-$4.6M |
 |
AmarinAMRN |
$1.7M |
 |
Gilead SciencesGILD |
-$233M |
 |
Anavex Life SciencesAVXL |
-$14M |
 |
Inovio PharmaceuticalsINO |
-$2.2M |
Insider Transactions
| Name | Transaction Date | Sold / Bought | Shares | Price | Value |
|---|---|---|---|---|---|
| Farid Adrienne | Nov 4, 2024 | Sell | 1,033 | $1.227 | $1,300 |
| Carr Douglas | Nov 4, 2024 | Sell | 283 | $1.227 | $350 |
| Quimi Daphne | Sep 12, 2024 | Buy | 5,000 | $1.5314 | $7,700 |
| Farid Adrienne | Aug 5, 2024 | Sell | 1,073 | $1.827 | $2,000 |
| Carr Douglas | Aug 5, 2024 | Sell | 289 | $1.827 | $530 |
| Russotti Gregory | Jul 26, 2024 | Sell | 586 | $2.5 | $1,500 |
| Russotti Gregory | Jul 24, 2024 | Sell | 1,600 | $2.5184 | $4,000 |
| Russotti Gregory | Jul 23, 2024 | Sell | 200 | $2.5 | $500 |
| Russotti Gregory | Jun 20, 2024 | Sell | 5,000 | $2.8357 | $14,000 |
| Russotti Gregory | Jun 5, 2024 | Sell | 5,000 | $2.9978 | $15,000 |
| Russotti Gregory | May 20, 2024 | Sell | 5,000 | $2.9955 | $15,000 |
| Russotti Gregory | May 6, 2024 | Sell | 5,000 | $3.1238 | $16,000 |
| Carr Douglas | May 3, 2024 | Sell | 257 | $3.106 | $800 |
| Farid Adrienne | May 3, 2024 | Sell | 913 | $3.106 | $2,800 |
| Russotti Gregory | Apr 22, 2024 | Sell | 5,000 | $3.0979 | $15,000 |
| Farid Adrienne | Mar 7, 2024 | Sell | 22,831 | $5.1396 | $120,000 |
| Farid Adrienne | Mar 6, 2024 | Sell | 30,684 | $4.9648 | $150,000 |
| Farid Adrienne | Feb 16, 2024 | Sell | 485 | $4.8624 | $2,400 |
| Farid Adrienne | Feb 6, 2024 | Sell | 1,784 | $4.487 | $8,000 |
| Carr Douglas | Feb 6, 2024 | Sell | 557 | $4.487 | $2,500 |
| Farid Adrienne | Feb 5, 2024 | Sell | 2,035 | $3.841 | $7,800 |
| Carr Douglas | Feb 5, 2024 | Sell | 643 | $3.841 | $2,500 |
| Borges Luis | Mar 23, 2023 | Sell | 15,597 | $3.55 | $55,000 |
| Borges Luis | Mar 22, 2023 | Sell | 65,698 | $3.7237 | $240,000 |
| Borges Luis | Mar 21, 2023 | Sell | 63,616 | $3.7706 | $240,000 |
What's the latest insider transaction for Century Therapeutics?
The most recent insider transaction for Century Therapeutics was conducted by Farid Adrienne, who sold 1,033 shares on November 4, 2024 at a price of $1.23 per share.
Which insider bought the most IPSC stock over the last two years?
Quimi Daphne has bought the most IPSC stock in the last 2 years, with a total value of $7,700.
Which insider has sold the most IPSC stock over the last two years?
Borges Luis has sold the most IPSC stock in the last 2 years, with a total value of $540,000.
What is the total value of insider transactions for Century Therapeutics (IPSC) in the last 2 years?
The total value of insider transactions for Century Therapeutics in the last 2 years is negative, amounting to -$910,000. This suggests that insiders have predominantly sold shares, which could reflect various personal or financial considerations rather than a straightforward outlook on the company's future performance.
How do insider transactions over the last 2 years reflect on Century Therapeutics' market confidence?
Over the last 2 years, insider transactions for Century Therapeutics have largely consisted of selling shares, which could suggest various personal or financial motivations among insiders. The higher number of sales might require investors to investigate further, considering insiders might have insights or reasons not immediately apparent to the public.
Why is monitoring insider trading activity important for investors?
Monitoring insider trading activity is important because it provides insights into the confidence levels of a company's insiders, such as executives and directors, regarding the company's future prospects. Insider buying can signal optimism, suggesting the stock may be undervalued, while insider selling might raise questions about the stock's upcoming performance. However, it's essential to consider that sales can also occur for personal financial reasons. Insider trading activity is a valuable indicator that, when combined with other data, can help inform investment decisions.
